LONDON (Reuters) - Instead of using a blood test to determine whether a man has prostate cancer, doctors might one day more accurately diagnose the condition using a new technique that measures a ...

Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023, according to NHS data. It’s also the second-deadliest form of the ...

As prostate cancer cases even among youngsters are increasing, a new at-home saliva test to help identify high-risk patients is here. According to experts, this can help find out the chances of ...

To check for possible prostate cancer, physicians most often use prostate-specific antigen (PSA) tests and digital rectal exams (DREs). For a firm diagnosis, they use core needle biopsies. This page ...

The Decipher Prostate Metastatic test is now available for metastatic prostate cancer, covered by Medicare for all risk levels. It helps clinicians determine which patients may benefit from treatment, ...

Professor Prabhakar Rajan has spoken out about the concerning rate of prostate cancer diagnoses and the one thing he wants men to do to tackle it ...

The study's testing accurately identified prostate cancer 91% of the time and accurately ruled out men without prostate cancer 84% of the time. A urine-based biomarker panel may be a promising, ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that its market-leading Decipher Prostate Genomic Classifier is the ...

Your prostate is an organ that makes some of the fluid that’s part of semen. It’s below your bladder and in front of your rectum. Prostate cancer happens when the cells in your prostate gland grow out ...